BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

36 related articles for article (PubMed ID: 919645)

  • 1. Re-Inventing Infectious Disease: Antibiotic Resistance and Drug Development at the Bayer Company 1945-80.
    Gradmann C
    Med Hist; 2016 Apr; 60(2):155-80. PubMed ID: 26971595
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Surveillance of R-plasmids.
    Rische H; Tschäpe H; Witte W
    Acta Microbiol Acad Sci Hung; 1977; 24(3):253-60. PubMed ID: 341659
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Ecology and epidemiological significance of infectious chemotherapeutic resistance].
    Tschäpe H; Rische H
    Beitr Hyg Epidemiol; 1974; 22():1-102. PubMed ID: 4462550
    [No Abstract]   [Full Text] [Related]  

  • 4. [Principles of therapy with antibiotics and chemotherapeutics].
    Falkenhagen U
    Zentralbl Gynakol; 1976; 98(23):1409-25. PubMed ID: 1014994
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Basic trends and the prospects for creating new synthetic chemotherapeutic preparations].
    Pershin GN
    Antibiotiki; 1980 Oct; 25(10):723-9. PubMed ID: 7425591
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Chemotherapeutic strategy and chemotherapeutic regimes].
    Rische H
    Z Gesamte Inn Med; 1977 Jul; 32(14):Suppl 214-8. PubMed ID: 919645
    [TBL] [Abstract][Full Text] [Related]  

  • 7. R-factors in gram-positive and gram-negative aerobic bacteria selected by antimicrobial therapy.
    Buu-Hoi A; Goldstein FW; Acar JF
    Scand J Infect Dis Suppl; 1986; 49():46-55. PubMed ID: 3547625
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Development of antituberculous drugs: current status and future prospects].
    Tomioka H; Namba K
    Kekkaku; 2006 Dec; 81(12):753-74. PubMed ID: 17240921
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antibiotic resistance: the perfect storm.
    Gould IM
    Int J Antimicrob Agents; 2009 Aug; 34 Suppl 3():S2-5. PubMed ID: 19596110
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Haemophilus, Actinobacillus, Pasteurella: mechanisms of resistance and antibiotic therapy.
    Willson PJ
    Can J Vet Res; 1990 Apr; 54 Suppl():S73-7. PubMed ID: 2193709
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Optimal use of modern antibiotics: emerging trends.
    Polk R
    Clin Infect Dis; 1999 Aug; 29(2):264-74. PubMed ID: 10476723
    [TBL] [Abstract][Full Text] [Related]  

  • 12.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 13.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 14.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 15.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 16.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 17.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 2.